All Access

Health Tech Deals

Standard

Health Tech Deals Thought Bubble

Thought Bubble

Health Tech Deals Alerts

Alert

mustard

BFD Expert Voices - Health Tech Deals

BFD Expert Voices

Ognomy Sleep, a virtual sleep medicine platform, raised a $20 million Series A, CEO Daniel Rifkin tells Axios exclusively.

The big picture: Investor interest in sleep medicine is building as care moves toward at-home diagnostics and remote monitoring.

"The  demand is there, but the bottleneck is awareness," Rifkin says. "You have a massive disorder where 80% of the patients remain undiagnosed."

Follow the money: Catalyst Investors led, with participation from Blue Heron Capital.

Ognomy will use the Series A to expand its clinician network, sales team and partnerships, aiming to grow about fivefold before a potential next financing, Rifkin says.

How it works: Ognomy connects patients with virtual sleep clinicians who manage at-home tests, diagnosis and treatment options, including CPAP, medication and surgery referrals.

The Buffalo, N.Y.-based company makes money primarily through insurance-covered care.

Zoom in: Rifkin says Ognomy uses AI in the background to streamline referrals, testing logistics and patient engagement, but not to make clinical decisions.

Between the lines: The sleep apnea category is gaining momentum from consumer wearables, GLP-1s, emerging non-CPAP therapies and demand for specialty care access.

"You don't have to live near a big metropolitan center to get high-quality care," Rifkin says. "You can live in rural Montana or North Dakota."

State of play: Investors have backed several sleep tech platforms in recent months.

Sleep tech startup Kimba raised $6.5 million in seed funding this month.

Smart sleep product maker Eight Sleep nabbed a $50 million Series D1 round at a $1.5 billion post-money valuation in March.

ProSomnus, a maker of a discreet sleep apnea device, secured $35 million in February. 

What's next: Rifkin said the longer-term goal is to take Ognomy beyond the U.S., using its smartphone-based virtual care model to expand access to sleep apnea care internationally.

Exclusive: Ognomy Sleep raises $20M for at-home testing

Investor interest in sleep medicine is building as care moves toward at-home diagnostics and remote monitoring.

Illustration of a bed with the duvet as a hundred dollar bill. 

Ognomy Sleep, a virtual sleep medicine platform, raised a $20 million Series A, CEO Daniel Rifkin tells Axios exclusively.The big picture: Investor interest in sleep medicine is building as care moves toward at-home diagnostics and remote monitoring.

topics

politics-policy

epstein-files

donald-trump

2026-midterm-elections

immigration

behind-the-curtain

race-and-equity

technology

privacy-tech-regulation

automation-and-ai

tiktok-news

big-tech

social-media

cybersecurity

economy

social-security

inflation

tariffs

federal-reserve

transportation

business

c-suite

retail-news

media

elon-musk

dealmaking

health

rfk-jr

drug-prices

axios-explains-abortion

public-health

world

israel

axios-explains-ukraine

iran

russia

china

energy-climate

nuclear-energy

climate-energy-policy

climate-change

extreme-weather

alternative-energy

electric-vehicles

science

emerging-tech

biomedicine

newsletters

charlotte

salt-lake-city

denver

fort-lauderdale

cincinnati

scottsdale

boulder

kansas-city

austin

chicago

dallas

detroit

atlanta

indianapolis

nashville

nw-arkansas

columbus

hollywood

washington-dc

north-of-cincy

mesa

richmond

san-francisco

boston

des-moines

houston

phoenix

miami

philadelphia

seattle

new-orleans

colorado-springs

huntsville

raleigh

san-antonio

twin-cities

pittsburgh

san-diego

tampa-bay

portland

cleveland

arapahoe

douglas

axios-local

axios-pro

axios-live

the-axios-show

Exclusive: Ognomy Sleep raises $20M for at-home testing

What to read next